A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.

Patil D, Slejko JF, Savitt JM, Mattingly Ii TJ

DOI: 10.1007/s41669-026-00668-5
Published: 2026 Sep
Container: PharmacoEconomics - open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s41669-026-00668-5,
  title = {A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.},
  author = {Patil D and Slejko JF and Savitt JM and Mattingly Ii TJ},
  year = {2026},
  journal = {PharmacoEconomics - open},
  doi = {10.1007/s41669-026-00668-5},
  url = {https://doi.org/10.1007/s41669-026-00668-5}
}

RIS

TY  - JOUR
TI  - A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.
AU  - Patil D
AU  - Slejko JF
AU  - Savitt JM
AU  - Mattingly Ii TJ
PY  - 2026
JO  - PharmacoEconomics - open
DO  - 10.1007/s41669-026-00668-5
UR  - https://doi.org/10.1007/s41669-026-00668-5
ER  -

APA

D, P., JF, S., JM, S., & TJ, M. I. (2026). A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.. PharmacoEconomics - open. https://doi.org/10.1007/s41669-026-00668-5

Source records

pubmed · retrieved 2026-09-26T04:57:58.775Z